<DOC>
	<DOCNO>NCT00242190</DOCNO>
	<brief_summary>This study examine propose research treatment evaluate addition oxaliplatin , chemotherapy agent , gemcitabine , another chemotherapy agent , radiation therapy treatment patient pancreatic cancer . The researcher already do study use gemcitabine radiation therapy together . They want build information previous research . The researcher believe combination chemotherapy radiation worth investigate treat pancreatic cancer . They use study determine type side effect occur treatment assess effective treatment control cancer .</brief_summary>
	<brief_title>Gemcitabine , Oxaliplatin Radiation Therapy Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patients must cytologic histologic confirmation carcinoma arise pancreas . Patients may stage pancreatic cancer metastatic , systemic disease burden asymptomatic small volume . Determination resectability must make prior registration . Patients must estimate life expectancy least 12 week Zubrod performance status &lt; = 2 . Patients must adequate organ function define follow : absolute neutrophil count &gt; = 1500/mm3 , platelet &gt; = 100,000/mm3 , serum Cr &lt; = 1.5 mg/dl , bilirubin &lt; 3.0 mg/dl , relief biliary obstruction present ( PTC tube endobiliary stent ) . Patients must free active systemic malignancy , ongoing infection , include HIV infection , serious uncontrolled , concomitant systemic disorder psychiatric condition would interfere safe delivery protocol therapy . Patients reproductive potential must agree use effective contraceptive method participation trial 6 month trial . Patient must aware investigational nature therapy provide write informed consent . Patients neuroendocrine tumor exclude . Patients must history previous chemotherapy pancreatic cancer abdominal radiation therapy . Patient must use investigational agent month enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>drug therapy</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>clinical trial</keyword>
</DOC>